It’s amazing how many investors are governed by their emotions.
Last time I looked big Pharma is still looking to acquire drugs that solve unmet needs. IHL is still working on developing those drugs and the company has $40 million cash in the bank.
GSK just bid US$2.1 billion to acquire Affinivax which has a pneumococcal vaccine. They didn’t put the handbrake on because of the NASDAQ or inflation.
GSK is the $100 billion market cap big Pharma that recently moved into the medicinal cannabis space.
IHL Price at posting:
29.0¢ Sentiment: Buy Disclosure: Held